A bumpier roll-out than expected
By Gail Wilensky, Ph.D. |
The roll-out of the health insurance marketplaces in October was not exactly the auspicious start for this important provision of ...
Read More the IRS and “your health care”
By Gail Wilensky, Ph.D. |
At most times, the IRS is one of America’s least loved institutions, but this past month has been a particularly ...
Read More India’s decision on Gleevec®: implications for the future
By Gail Wilensky, Ph.D. |
India’s Supreme Court recently rejected a request from Novartis for a second patent for its cancer drug Gleevec. Forty other ...
Read More Is the slowdown in healthcare spending sustainable?
By Gail Wilensky, Ph.D. |
In these most political of times, it should come as no surprise that the recent slowdown in healthcare spending has ...
Read More Subscribe!
Please enter your name.
Please enter a valid email address.
Thanks for subscribing! Please check your email for further instructions.
Something went wrong. Please check your entries and try again.